Increased cardiovascular risk after pre-eclampsia in women with dysglycaemia

Diabetic Medicine

Volumn 30, Issue 1, 2013, Pages

  Mcdonald, S D ^a   Yusuf, S ^a,b,c,d   Walsh, M W ^a,c,e   Lonn, E ^b,c,d   Teo, K ^a,b,c,d   Anand, S S ^a,c,d   Pogue, J ^a,d   Islam, S ^d   Devereaux, P J ^a,b,c,d   Gerstein, H C ^a,c,d,f  

^a MCMASTER UNIVERSITY   (Canada)

^b Division of Cardiology   (Canada)

^c Division of Cardiology ^*  (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e Division of Nephrology   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID;

ADULT; ALBUMIN CREATININE RATIO; ALBUMINURIA; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DYSGLYCEMIA; ELECTROCARDIOGRAM; FEMALE; HIGH RISK PATIENT; HIP CIRCUMFERENCE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL HISTORY; ORAL GLUCOSE TOLERANCE TEST; PREECLAMPSIA; RENAL SYSTEM PARAMETERS; URINALYSIS; WAIST CIRCUMFERENCE;

ALBUMINURIA; ANALYSIS OF VARIANCE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84871096508     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12033     Document Type: Article

References (25)

1. National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990; 163: 1691-1712.
2. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366: 1797-803.
3. Douglas KA, Redman CW. Eclampsia in the UK. Br Med J 1994; 309: 1395-1400.
4. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 1988; 158: 80-83.
5. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of pre-eclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008; 156: 918-930.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc 2003; 289: 2560-2572.
7. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-226.
8. Gerstein H, Yusuf S, Riddle MC, Ryden L. Origin Trial Investigators. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 2008; 155: 26-32.
9. McDonald SD, Yusuf S, Sheridan P, Anand SS, Gerstein HC. Dysglycemia and a history of reproductive risk factors. Diabetes Care 2008; 31: 1635-1638.
10. Coolman M, de Groot CJ, Jaddoe VW, Hofman A, Raat H, Steegers EA. Medical record validation of maternally reported history of pre-eclampsia. J Clin Epidemiol 2010; 63: 932-937.
11. Diehl CL, Brost BC, Hogan MC, Elesber AA, Offord KP, Turner ST, et al. Pre-eclampsia as a risk factor for cardiovascular disease later in life: validation of a pre-eclampsia questionnaire. Am J Obstet Gynecol 2008; 198: e11-e13.
12. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
13. American Diabetes Association. Clinical recommendations 2001: diabetic nephropathy. Diabetes Care 2001; 24: S69-S72.
14. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
15. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
16. McGorrian C, Yusuf S, Islam S, Jung H, Rangarajan S, Avezum A et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. Eur Heart J 2011; 32: 581-589.
17. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J 2001; 323: 1213-1217.
18. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997; 77: 154-158.
19. Funai EF, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L et al.Long-term mortality after pre-eclampsia. Epidemiology 2005; 16: 206-215.
20. Thadhani R, Solomon CG. Pre-eclampsia-a glimpse into the future? N Engl J Med 2008; 359: 858-860.
21. Roberts JM, Taylor RN, Goldfien A. Endothelial cell activation as a pathogenetic factor in pre-eclampsia. Semin Perinatol 1991; 15: 86-93.
22. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39: 445-459.
23. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74: 772-776.
24. Williams D. Pregnancy: a stress test for life. Curr Opin Obstetr Gynecol 2003; 15: 465-471.
25. Sibai BM, El-Nazer A, Gonzalez-Ruiz A. Severe pre-eclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986; 155: 1011-1016.